Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 25

Results For "NIV"

1031 News Found

Foxconn invests US$30 million in Robocore to expand into elderly care robotics market
Digitisation | August 20, 2025

Foxconn invests US$30 million in Robocore to expand into elderly care robotics market

Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO


European Commission grants approval of Ogsiveo
News | August 18, 2025

European Commission grants approval of Ogsiveo

OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors


STEER World achieves 200 kg/hr continuous granulation with patented INTEGRAAL system
News | August 17, 2025

STEER World achieves 200 kg/hr continuous granulation with patented INTEGRAAL system

The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules


Centrient Pharmaceuticals joins UNGC
Sustainability | August 12, 2025

Centrient Pharmaceuticals joins UNGC

Reinforcing commitment to ethical and sustainable growth


Gland Pharma Q1 FY26 YoY PAT up by 50% to Rs. 216 Cr
News | August 06, 2025

Gland Pharma Q1 FY26 YoY PAT up by 50% to Rs. 216 Cr

Cenexi reports an EBITDA breakeven for the quarter


Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations
People | August 01, 2025

Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations

Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics


Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP
Sustainability | July 31, 2025

Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP

Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant


Torrent Pharmaceuticals appoints Aman Mehta as MD
People | July 29, 2025

Torrent Pharmaceuticals appoints Aman Mehta as MD

Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York


Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business
People | July 29, 2025

Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business

His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors